US Patent Issued to Sanofi Biotechnology on Oct. 14 for "Method of treating an eye-related disorder by administering an anti-interleukin-4 receptor alpha (anti-IL-4RAlpha) antibody" (American, French Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,440,562, issued on Oct. 14, was assigned to Sanofi Biotechnology (Paris).

"Method of treating an eye-related disorder by administering an anti-interleukin-4 receptor alpha (anti-IL-4RAlpha) antibody" was invented by Paul Bryce (Bridgewater, N.J.), Emanuele De Rinaldis (Bridgewater, N.J.), Ramon Antonio Hernandez Vecino (Paris), Francisco Javier Jimenez Jimenez (Brookline, Mass.) and Cliona Marie Molony (Bridgewater, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are methods of treating various disorders with anti-IL-4RAlpha antibodies and fragments thereof."

The patent was filed on Aug. 4, 2023, under Application No. 18/365,505.

*For fu...